Cedars-Sinai Names Director of Congenital Heart Program
Andy Y. Shin, MD, Will Lead an Integrated Congenital Heart Program Spanning Fetal Diagnosis Through Childhood, Adolescence and Adulthood
Cedars-Sinai has named Andy Y. Shin, MD, as director of Congenital Heart within the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai. Dr. Shin will also serve as director of Pediatric Cardiology and have an appointment in the Department of Pediatrics in Cedars-Sinai Guerin Children’s.
Dr. Shin will lead the continued development of an integrated congenital heart program spanning fetal diagnosis through childhood, adolescence and adulthood.
“We are delighted to have Dr. Shin working across the Smidt Heart Institute, Guerin Children’s and our multidisciplinary programs,” said Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute at Cedars-Sinai.
Susan Cheng, MD, MMSc, MPH, chair of the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai, said Dr. Shin will “advance clinical excellence, programmatic growth, research and education while strengthening the connections and continuum of care for all our patients affected by fetal, pediatric or adult congenital heart disease.”
Dr. Shin joins Cedars-Sinai from Stanford University, where he is clinical professor of Pediatrics. As a Stanford faculty member, he spent nearly two decades building programs at the intersection of pediatric and adult congenital heart care. Dr. Shin served as executive medical director for Innovations and Clinical Effectiveness, medical director for Quality and Outcomes in the Moore Children’s Heart Center, and medical director of Systems Utilization Research.
“Dr. Shin is widely respected by colleagues across the field not only for his academic and clinical accomplishments but also for his generous and thoughtful mentorship of students, medical trainees and faculty,” said Ophir Klein, MD, PhD, executive director of Guerin Children’s and executive vice dean of Children’s Health. “We are eager for him to lead the next chapter of our growth and impact in congenital heart care.”
Beyond his prominent roles at Stanford, Dr. Shin also is recognized nationally for his leadership as an investigator, educator and innovator in congenital heart disease.
He has led a multicenter consortium of hospitals across North America investigating interventions aimed at reducing variation in hospital length of stay. His scholarship has addressed outcomes following congenital heart surgery, pediatric cardiac critical care, clinical decision support, and the use of mathematical modeling and systems engineering to address complex challenges in healthcare delivery.
Dr. Shin earned his medical degree from the University of California, San Francisco (UCSF), and completed his pediatrics residency, chief residency and fellowship training in pediatric cardiology and pediatric critical care medicine at Boston Children’s Hospital and Harvard Medical School.
“I look forward to partnering with Cedars-Sinai leadership to develop a vanguard integrated, lifespan model of congenital heart care,” Dr. Shin said.
Dr. Shin said the Cedars-Sinai program will accelerate the translation of innovation into better patient outcomes by integrating exceptional clinical care with data science, advanced analytics and emerging technologies.
The program will draw on the broader capabilities of the Smidt Heart Institute, Guerin Children’s and Cedars-Sinai to create a comprehensive approach to congenital cardiovascular disease across the lifespan.
Cedars-Sinai Health Sciences University is advancing groundbreaking research and educating future leaders in medicine, biomedical sciences and allied health sciences. Learn more about the university.